Intranasal beclomethasone as an adjunct to treatment of chronic middle ear effusion

Annals of Allergy, Asthma and Immunology

Volumn 80, Issue 2, 1998, Pages 198-206

  Tracy, James M ^a   Demain, Jeffrey G ^a   Hoffman, Kristina M ^a   Goetz, David W ^a,b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BECLOMETASONE; CEFIXIME; COTRIMOXAZOLE; ERYTHROMYCIN; SULFAFURAZOLE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHILD; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MIDDLE EAR EFFUSION; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TYMPANOMETRY;

EID: 0031939286     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62956-0     Document Type: Article

References (40)

1. Teele DW, Klein JO, Rosner B, et al. Middle ear disease and the practice of pediatrics: burden during the first five years of life. JAMA 1983;249:1026-9.
2. Bluestone CD. Modern management of otitis media. Pediatr Clin N Am 1989;36:1371-87.
3. Kline MW. Otitis media. In: Oski FA, DeAngelis CD, Feigin RD, et al, eds. Principles and practice of pediatrics (2nd edition). Philadelphia: JB Lippincott Co, 1990:974-6.
4. Brook IB, Yocum P. Quantitative bacterial cultures and beta-lactamase activity in chronic suppurative otitis media. Ann Otol Rhinol Laryngol 1989; 98:293-7.
5. Cantekin EI, Mandel EM, Bluestone CD, et al. Lack of efficacy of a decongestant-antihistamine combination for otitis media with effusion ("secretory" otitis media) in children. N Engl J Med 1983;308:297-301.
6. Bluestone CD, Cantekin EI, Beery QC. Effect of inflammation on the ventilatory function of the eustachian tube. Laryngoscope 1977;87:493-507.
7. Gates GA, Folbre TW. Indication for adenoidectomy. Arch Otolaryngol Head Neck Surg 1986;112:501-2.
8. Gates GA, Avery CA, Prihoda TJ, Cooper JC. Effectiveness of adenoidectomy and tympanostomy tubes in the treatment of chronic otitis media with effusion. N Engl J Med 1987;317: 1444-51.
9. Berman S, Grose K, Nuss R, et al. Management of chronic middle ear effusion with prednisone combined with trimethoprim-sulfamethoxazole. Pediatr Infect Dis J 1990;9:533-8.
10. Schappert SM. National ambulatory medical care survey: 1991 summary. Vital Health Statistics (Series 13) 1994;116:1-10.
11. Daly K. Risk factors for otitis media sequelae and chronicity. Ann Otol Rhinol Laryngol 1994;103:39-42.
12. Arcia E, Roberts JE. Otitis media in early childhood and its association with sustained attention in structured situations. J Dev Behav Pediatr 1993; 14:181-3.
13. Clinical practice guideline number 12. Otitis media with effusion in young children. Washington DC: US Department of Health and Human Services; July 1994. Agency for Health Care Policy and Research publication 94-0623.
14. Bluestone CD. Eustachian tube function: physiology, pathophysiology, and role of allergy in pathogenesis of otitis media. J Allergy Clin Immunol 1983;72:242-51.
15. Fireman P. Newer concepts of the pathogenesis of otitis media with effusion. Immunol Allergy Clin N Am 1987;7(1):133-45.
16. Skonner DP, Stillwagon PK, Cassel-brandt ML, et al. Inflammatory mediators in chronic otitis media with effusion. Otolaryngol Head Neck Surg 1988;114:1131-3.
17. Gates GA, Avery CA, Cooper JC, Prihoda TJ. Chronic secretory otitis media: effects of surgical management. Ann Otol Rhinol Laryngol 1989; 98:2-32.
18. Macknin MK, Jones PK. Oral dexamethasone for treatment of persistent middle ear effusion. Pediatrics 1985; 75:329-35.
19. Giebink GS, Batalden PB, Le CT, et al. A controlled trial comparing three treatments for chronic otitis media with effusion. Pediatr Infect Dis J 1990;9:33-40.
20. Schwart RH, Puglese J, Schwartz DM. Use of a short course of prednisone for the treatment of middle ear effusion: a double blind cross-over study. Ann Otol Rhinol Laryngol 1980;89:(Suppl 68)296-300.
21. Puhakka H, Haapaniemi J, Tuohimaa P, et al. Peroral prednisolone in the treatment of middle ear effusion in children: a double-blind study. Auris Nasus Larynx 1985;12(Suppl 1): S268-S271.
22. Lambert PR. Oral steroid therapy for chronic middle ear perfusion: a double-blind cross-over study. Otolaryngol Head Neck Surg 1986;95:193-9.
23. Hearey C, Hokanson J, Ury H, et al. Lack of efficacy of short-term prednisone, trimethoprim-sulfamethoxazole, alone or combined, in persistent otitis media with effusion: seasonal entry as possible determinant of outcome [Abstract]. Am J Dis Child 1990;144: 420.
24. Podoshin L, Fradis M, Ben-David Y, Faraggi D. The efficacy of oral steroids in the treatment of persistent otitis media with effusion. Arch Otolaryngol Head Neck Surg 1990;116: 1404-6.
25. Daly K, Giebink GS, Batalden PB, et al. Resolution of otitis media with effusion with the use of a stepped treatment regimen of trimethoprim-sulfamethoxazole and prednisone. Pediatr Infect Dis J 1992;10:500-6.
26. Schwartz RH, Schwartz DM, Grandfast KM. Intranasal beclomethasone in the treatment of middle ear effusion: a pilot study. Ann Allergy 1980;45: 284-7.
27. Lindholdt T, Kortholm B. Beclomethasone nasal spray in the treatment of middle-ear effusion-a double blind study. Int J Pediatr Otorhinolaryngol 1982;4:133-7.
28. Shapiro GG, Bierman CW, Furukawa CT, et al. Treatment of persistent eustachian tube dysfunction in children with aerosolized nasal dexamethasone phosphate versus placebo. Ann Allergy 1982;49:81-5.
29. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993; 148(Suppl):S1-S26.
30. Mabry RL. Intranasal corticosteroids and cromolyn. Am J Otolaryngol 1993;14:295-300.
31. Perisco M, Podoshin L, Fradis M. Otitis media with effusion: a steroid and antibiotic therapeutic trial before surgery. Ann Otol 1978;87:191-6.
32. Demain JG, Goetz DG. Pediatric adenoidal hypertrophy and nasal airway obstruction: reduction with aqueous nasal beclomethasone. Pediatrics 1995;95:355-64.
33. Rosenfeld RM. New concepts for steroid use in otitis media with effusion. Clin Pediatr 1992;31:615-21.
34. Kasper WJ, Howe PM. Fatal varicella after a single course of corticosteroids. Pediatr Infect Dis J 1990;9:729-32.
35. Shore SC, Weinberg EG. Beclomethasone dipropionate aerosol in treatment of perennial allergic rhinitis in children. Arch Dis Child 1977;52:486-8.
36. Kobayashi RH, Tinkelman DG, Reese ME, et al. Beclomethasone dipropionate aqueous nasal spray for allergic rhinitis in children. Ann Allergy 1989; 62:205-8.
37. Bisgaard H, Nielsen MD, Andersen B, et al. Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide. J Allergy Clin Immunol 1988; 81:1088-95.
38. Prahl P, Wilken-Jensen K, Mygind N. Beclomethasone dipropionate aerosol in treatment of hay fever in children. Arch Dis Child 1975;50:875-8.
39. Neuman I, Toshner D, Beclomethasone dipropionate in pediatric perennial extrinsic rhinitis. Ann Allergy 1978;40:346-8.
40. Simons FER. Allergic rhinitis: recent advances. Pediatric Clin N Am 1988; 35:1053-74.